Repare Therapeutics Inc. (RPTX)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 51.13M 131.83M 7.60M 135.00K - - -
Cost of Revenue 131.20M 4.18M 3.34M 1.79M 968.00K 407.00K 102.00K
Gross Profit -80.07M 127.65M 4.26M -1.65M -968.00K -407.00K -102.00K
Operating Income -116.22M -19.80M -108.66M -54.30M -26.38M -12.82M -6.17M
Interest Income 13.33M 5.63M 259.00K 240.00K - - -
Pretax Income -103.18M -13.90M -108.59M -54.74M -27.02M -14.25M -7.80M
Net Income -93.80M -29.05M -106.91M -53.42M -27.22M -14.28M -7.80M
Selling & General & Admin 33.76M 32.56M 26.21M 14.35M 5.38M 2.91M 1.77M
Research & Development 133.59M 119.07M 90.05M 40.09M 21.00M 9.91M 4.40M
Other Expenses - -43.00K -41.00K -16.00K -1.36M -1.14M -1.47M
Operating Expenses 167.36M 151.63M 116.26M 54.44M 26.38M 12.82M 6.17M
Interest Expense - - - - - - -
Selling & Marketing Expenses - - - - - - -
Cost & Expenses 167.65M 151.63M 116.26M 54.44M 26.38M 12.82M 6.17M
Income Tax -9.38M 15.15M -1.68M -1.32M 195.00K 35.00K 147.00K
Shares Outstanding (Basic) 42.09M 41.92M 37.82M 36.90M 36.67M 15.79M 15.79M
Shares Outstanding (Diluted) 42.09M 41.92M 37.82M 36.90M 36.67M 15.79M 15.79M
EPS (Basic) -2.23 -0.69 -2.83 -1.45 -0.74 -0.9 -0.49
EPS (Diluted) -2.23 -0.69 -2.83 -1.45 -0.74 -0.9 -0.49
EBITDA -114.27M -17.82M -107.19M -53.41M -25.49M -13.51M -7.53M
Depreciation & Amortization 1.95M 4.18M 3.34M 1.79M 968.00K 407.00K 102.00K